Company news
Viridian Therapeutics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming Conferences
January 22, 2020
miRagen Announces Major Changes to Company’s Strategy
December 10, 2019
miRagen to Present at the Evercore ISI HealthCONx Conference 2019
November 25, 2019
miRagen Reports Third Quarter 2019 Results and Provides Corporate Update
November 6, 2019
miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference Today
October 27, 2019
miRagen Therapeutics to Report Third Quarter 2019 Financial Results and Host a Conference Call
October 21, 2019
miRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel Growth
October 15, 2019
Calls
The 5 newest of 7 calls. Every call is listed under its year.
- Viridian Therapeutics (NASDAQ:VRDN) Q3 2026 Earnings Call
Nov 4, 2026
Transcript - Viridian Therapeutics (NASDAQ:VRDN) Q4 2024 Earnings Call
Mar 12, 2025
Transcript - Viridian Therapeutics (NASDAQ:VRDN) Q1 2024 Earnings Call
May 8, 2024
Transcript - Viridian Therapeutics (NASDAQ:VRDN) Q1 2023 Earnings Call
May 9, 2023
Transcript - Viridian Therapeutics (NASDAQ:VRDN) Q4 2022 Earnings Call
Mar 8, 2023
Transcript
Decks
The 5 newest of 24 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 15 slides · Nov 4, 2026
- Corporate Update (June 2026)
Corporate update · 28 slides · Jun 29, 2026
- Technical Presentation (May 2026)
Technical · 20 slides · May 5, 2026
- Investor Presentation (May 2026)
Investor deck · 71 slides · May 5, 2026
- Technical Presentation (March 2026)
Technical · 20 slides · Mar 30, 2026